Related Experiment Video
Updated: Jun 25, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Defining, identifying and addressing problematic polypharmacy within multimorbidity in primary care: a scoping review
Jung Yin Tsang1,2, Matthew Sperrin2,3, Thomas Blakeman4,2
1Centre for Primary Care and Health Services Research, School of Health Sciences, The University of Manchester Division of Population Health Health Services Research and Primary Care, Manchester, UK jungyin.tsang@manchester.ac.uk.
Current polypharmacy interventions lack effectiveness due to poor patient targeting. Improved strategies must consider patient factors and clinical appropriateness for better health outcomes in multimorbidity.
Area of Science:
- Gerontology
- Primary Care Medicine
- Clinical Pharmacy
Background:
- Polypharmacy and multimorbidity present growing healthcare challenges.
- Existing interventions have not consistently improved patient health outcomes.
- Ineffective patient targeting may be a key limitation.
Purpose of the Study:
- To review how patients with polypharmacy are targeted for interventions.
- To understand definitions of polypharmacy.
- To identify methods for targeting problematic polypharmacy in primary care.
Main Methods:
- A scoping review was conducted following Joanna Briggs Institute guidelines.
- Searches covered major databases (Medline, Embase, CINAHL, Cochrane) and clinical trial registries from 2004-2024.
- Included studies focused on problematic polypharmacy in multimorbidity within primary care, encompassing diverse evidence types.
Main Results:
- 157 articles were included in the review.
- Patient targeting often uses simple medication counts, ignoring clinical appropriateness and patient history.
- Current methods fail to identify all patients needing intervention due to inconsistencies and neglect of multimorbidity.
Conclusions:
- More effective strategies are needed to target patients experiencing polypharmacy.
- Interventions should incorporate patient perspectives, individual factors, and clinical appropriateness.
- Developing a standardized measure for problematic polypharmacy, adjusted for multimorbidity, is recommended.
More Related Videos
Related Concept Videos
Drug Therapy
Antianxiety Medications
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Methods of Documentation II: POMR
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Psychosis: Goals of Pharmacotherapy

